Mayo Clinic Multiple Myeloma Translational Program
Mayo Clinic Multiple Myeloma SPORE
['FUNDING_OTHER'] · MAYO CLINIC ARIZONA · NIH-11176751
This program turns lab discoveries into new tests and treatments for people with multiple myeloma.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MAYO CLINIC ARIZONA (nih funded) |
| Locations | 1 site (SCOTTSDALE, UNITED STATES) |
| Trial ID | NIH-11176751 on ClinicalTrials.gov |
What this research studies
This program brings Mayo Clinic doctors and laboratory teams at Rochester, Jacksonville, and Phoenix together to move scientific findings toward patient care. They collect patient blood and tissue samples, use bioinformatics to find tumor markers, and develop antibody-based and other targeted therapies. When findings look promising they open clinical trials so patients can try new options and help improve future care.
Who could benefit from this research
Good fit: People diagnosed with multiple myeloma, including newly diagnosed and relapsed patients who can visit or be referred to a Mayo Clinic site, are the main candidates for related trials and sample donation.
Not a fit: People without multiple myeloma or those who cannot travel to or meet eligibility requirements for Mayo Clinic trials are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, the program could lead to better diagnostic markers, more targeted therapies, and expanded clinical trial options for people with multiple myeloma.
How similar studies have performed: Previous translational myeloma programs have produced clinically used biomarkers and trials, and antibody-based approaches similar to those here have already shown promising results while some ideas remain experimental.
Where this research is happening
SCOTTSDALE, UNITED STATES
- MAYO CLINIC ARIZONA — SCOTTSDALE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BERGSAGEL, PETER LEIF — MAYO CLINIC ARIZONA
- Study coordinator: BERGSAGEL, PETER LEIF
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.